ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

11.76

-0.20 (-1.69%)

Sep 14, 2026, 4:00 PM EDT - Market closed

Assets	$1.98M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	165,519
Dividend (ttm)	$0.79
Dividend Yield	6.69%
Ex-Dividend Date	Jun 24, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	5,847
Open	11.91
Previous Close	11.96
Day's Range	11.68 - 11.91
52-Week Low	10.51
52-Week High	28.48
Beta	-1.19
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange NASDAQ

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-199.88% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-25.86%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-37.39%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-38.44%
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-48.92%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-49.27%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 24, 2026	$0.1366	Jun 30, 2026
Mar 25, 2026	$0.13714	Mar 31, 2026
Dec 24, 2025	$0.20514	Dec 31, 2025
Sep 24, 2025	$0.30854	Sep 30, 2025
Jun 25, 2025	$0.2161	Jul 1, 2025
Mar 26, 2025	$0.2651	Apr 1, 2025

Full Dividend History

Performance

BIS had a total return of -55.90% in the past year, including dividends. Since the fund's inception, the average annual return has been -33.00%.